PEG-LYTE Drug Patent Profile
✉ Email this page to a colleague
When do Peg-lyte patents expire, and what generic alternatives are available?
Peg-lyte is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in PEG-LYTE is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PEG-LYTE?
- What are the global sales for PEG-LYTE?
- What is Average Wholesale Price for PEG-LYTE?
Summary for PEG-LYTE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 168 |
| DailyMed Link: | PEG-LYTE at DailyMed |
US Patents and Regulatory Information for PEG-LYTE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | PEG-LYTE | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous | FOR SUSPENSION;ORAL | 073098-001 | Aug 31, 1993 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
